Concepedia

Author

Michael J. Jelinek

University of ChicagoORCID

Also Known As

Alfonso Berrocal Jaime, M JELINEK, M Jelinek, M. Jelinek, M.J. Jelinek, MICHAEL J. JELINEK, Michael J Jelinek, Michael J. Jelinek, Michael Jelinek

43

Publications

320

Citations

10

H-Index

46

Concepts

All Affiliations

University of ChicagoRush University Medical CenterChicago Department of Public HealthNorthwestern University
MJ

About

Michael J. Jelinek is an author at University of Chicago specializing in radiation oncology, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

175

2

Business

1

1

14

3

Health Sciences

1

1

12

4

Public Health

1

1

14

5

Environmental Health

1

1

14

Michael J. Jelinek

×

8

Publications

235

Citations

8

H-Index

YearCitations

A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison,

Journal of Thoracic Oncology

2021

122

Management of Early Head and Neck Cancer in Elderly Patients

Michael J. Jelinek, Adam Howard, Daniel J. Haraf,

Journal of Oncology Practice

2018

21

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

Michael J. Jelinek, Nathan R. Foster, Alexander Zoroufy,

Oral Oncology

2021

20

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer

Ari J. Rosenberg, Aditya Juloori, Michael J. Jelinek,

JAMA Oncology

2025

17

Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase‐Associated Lipocalin and Cystatin C

Michael J. Jelinek, Sang Mee Lee, Alicia Wyche Okpareke,

Clinical and Translational Science

2018

15

Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial.

Ari J. Rosenberg, Aditya Juloori, Nishant Agrawal,

Journal of Clinical Oncology

2023

14

Air pollution is associated with increased incidence-rate of head and neck cancers: A nationally representative ecological study

Henrique Ochoa Scussiatto, Kerstin Stenson, Samer Al‐Khudari,

Oral Oncology

2024

14

Randomized phase I trial to evaluate <i>C</i>oncurrent <i>o</i>r <i>S</i>equential <i>I</i>pilimumab, <i>N</i>ivolumab, and stereotactic body <i>R</i>adiotherapy in patients with stage IV non-small cell lung cancer (<i>COSINR Study</i>).

Jyoti D. Patel, Christine M. Bestvina, Theodore Karrison,

Journal of Clinical Oncology

2020

12

Page 1